Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis-Reference-Cited by-同舟云学术

Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis

Published:2020-08 Issue:4 Volume:155 Page:165-170
ISSN:0025-7753
Container-title:Medicina Clínica
language:en
Short-container-title:Medicina Clínica

Author:

Yao Tian-Tian,Qian Jian-Dan,Wang Gui-Qiang

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Electronic address eee;European Association for the Study of the L. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol.,2017

2. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases;Lindor;Hepatology.,2019

3. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid;Pares;Gastroenterology.,2006

4. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis;Corpechot;Gastroenterology.,2005

5. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis;Corpechot;N Engl J Med.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment;Cell & Bioscience;2024-06-15

2. Biological synthesis of ursodeoxycholic acid;Frontiers in Microbiology;2023-02-24

3. Colangitis biliar primaria: caracterización de una cohorte retrospectiva;Hepatología;2022-07-05